Oncomine Dx Target Test for Non-Small Cell Lung Cancer
Thermo Fisher ScientificOne test that can expedite NSCLC treatment selection decisions. The Oncomine Dx Target Test is the first targeted NGS-based in vitro diagnostic test for NSCLC, simultaneously delivering multiple biomarker results from one sample within four days and helping inform treatment decisions.